Bank Of America Corp Cyclerion Therapeutics, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.42 - $18.8 $19 - $883	47 Added 4700.0%	48 $0
Q3 2022 Nov 14, 2022	SELL	$0.58 - $18.2 $16 - $509	-28 Reduced 96.55%	1 $0
Q2 2022 Aug 12, 2022	SELL	$0.47 - $1.29 $1,147 - $3,150	-2,442 Reduced 98.83%	29 $0
Q1 2022 May 16, 2022	BUY	$0.96 - $1.78 $1,923 - $3,567	2,004 Added 429.12%	2,471 $3,000
Q4 2021 Feb 08, 2022	SELL	$1.56 - $2.99 $85 - $164	-55 Reduced 10.54%	467 $1,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $14,995 - $22,686	-5,493 Reduced 91.32%	522 $2,000
Q2 2021 Sep 13, 2021	BUY	$2.18 - $4.29 $13,112 - $25,804	6,015 New	6,015 $23,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $153M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.